Purchase Order 75N93023P01310
Award Date 9/18/23
Potential Completion Date 12/29/23
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $23,491 purchase order to Nanostring Technologies, Inc. of Seattle, Washington. The firm fixed price order is for NANOSTRING CONSUMABLE COSMX/CMX RNA ASSAYS in support of AMBIS 2186472 from September 15, 2023 through December 29, 2023. As a leading provider of advanced tools for biomedical research using its proprietary nCounter Analysis system, Nanostring will deliver its consumable assays to...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $22,941 firm fixed price purchase order to Nanostring Technologies, Inc. of Seattle, Washington. The contract is for the delivery of RNA consumables to support assay activity. No additional details were provided regarding the specific assays or research being supported. The place of performance is Nanostring's headquarters in Seattle. The period of...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $21,000 purchase order to Nanostring Technologies, Inc. to provide RNA consumables in support of continued assay activity. As a sole-source contract, Nanostring will deliver their proprietary RNA consumables from their headquarters in Seattle, Washington to support ongoing research efforts at NIH/NIAID through mid-November 2023. No subcontractors or set-aside designations were specified. NIAID...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $24,191 purchase order to Nanostring Technologies, Inc. of Seattle, Washington. Under this firm fixed price contract, Nanostring will provide RNA consumables to support continued assay activity for the NIH/NIAID. No major subcontractors or set aside designations were indicated. This purchase order was awarded to support the NIH/NIAID's ongoing work...
- Nanostring Technologies, Inc. has been awarded a firm fixed price purchase order valued at ten thousand two hundred twenty four dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the contract, Nanostring will provide its XT HS HostResponse assay kits and related supplies to support the NIH's infectious disease research efforts. As the prime contractor, Nanostring will deliver four assay kits priced at three thousand three hundred eleven...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $247,000 firm fixed price purchase order to Nanostring Technologies, Inc. of Seattle, Washington. The contract is for COSMX SMI FOR CELL IMAGING services to support the agency's research efforts. Performance will take place in Seattle through April 2024. No set aside designation or subcontractors were indicated. This purchase augments NIH/NIAID's ongoing...
- Nanostring Technologies, Inc. has been awarded a firm fixed price purchase order valued at $22,941 by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The award has no set-aside designation and work is to be completed by December 31, 2023. As a manufacturer of life science tools for translational research and molecular diagnostics, Nanostring will likely provide specialized equipment, consumables, or services to support genomic and molecular analysis...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a firm fixed price purchase order valued at $15,366 to Nanostring Technologies, Inc. to deliver consumable products supporting genomic analysis on the GeoMx Next Generation Sequencing platform. As a manufacturer of life science tools for translational research and molecular diagnostics, Nanostring will provide RNA biological products and consumables tailored to the agency's biomedical...
- Nanostring Technologies, Inc. has been awarded a $24,641 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide CMX KITS from Nanostring Technologies Inc. The place of performance will be Nanostring's facilities located in Seattle, Washington. The firm fixed price order is for the period of September 18, 2023 through November 18, 2023. No additional details were provided regarding the original solicitation or use of the CMX KITS...
- Nanostring Technologies, Inc. has been awarded a $12,399 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide master kits and primers. The products will support research efforts at Nanostring's place of performance in Seattle, Washington through December 2023. A firm fixed price was established for this acquisition of molecular diagnostic tools, with no subcontractors involved. This purchase augments NIH/NIAID's ongoing work...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $15,000 purchase order to Nanostring Technologies, Inc. to provide consumable RNA assays for the COSMX/CMX platform. The assays will support research efforts taking place in Seattle, Washington through December 2023. As a firm fixed price contract, Nanostring will deliver the specified RNA assays for the agreed upon total value. The award utilizes an existing Governmentwide Acquisition Contract vehicle and does not have any small business set aside designations. It will support the NIH's efforts to advance understanding of human health and combat serious diseases through collaborative scientific research.
Generated 12/24/23, 3:53 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 9/15/23 |